Lung tissue remodelling in MCT-induced pulmonary hypertension: a proposal for a novel scoring system and changes in extracellular matrix and fibrosis associated gene expression.

Marcus Franz; Katja Grün; Stefan Betge; Ilonka Rohm; Bernadin Ndongson-Dongmo; Reinhard Bauer; P Christian Schulze; Michael Lichtenauer; Iver Petersen; Dario Neri; Alexander Berndt; Christian Jung

doi:10.18632/oncotarget.13220

Lung tissue remodelling in MCT-induced pulmonary hypertension: a proposal for a novel scoring system and changes in extracellular matrix and fibrosis associated gene expression.

Marcus Franz
, Katja Grün
, Stefan Betge
, Ilonka Rohm
, Bernadin Ndongson-Dongmo
, Reinhard Bauer
, P Christian Schulze
, Michael Lichtenauer (Co-Autor/-in)
, Iver Petersen
, Dario Neri
, Alexander Berndt
, Christian Jung

Universitätsklinik für Innere Medizin 2 - Kardiologie, Internistische Intensivmedizin und Notaufnahme

Publikation: Beitrag in Fachzeitschrift › Originalarbeit › Begutachtung

14 Quellenangaben (Web of Science)

Originalsprache	Englisch
Seiten (von - bis)	81241-81254
Fachzeitschrift	Oncotarget
Jahrgang	7
Ausgabenummer	49
DOIs	https://doi.org/10.18632/oncotarget.13220
Publikationsstatus	Veröffentlicht - 2016

Zugriff auf Dokument

10.18632/oncotarget.13220

Dieses zitieren

Franz, M., Grün, K., Betge, S., Rohm, I., Ndongson-Dongmo, B., Bauer, R., Schulze, P. C., Lichtenauer, M., Petersen, I., Neri, D., Berndt, A., & Jung, C. (2016). Lung tissue remodelling in MCT-induced pulmonary hypertension: a proposal for a novel scoring system and changes in extracellular matrix and fibrosis associated gene expression. Oncotarget, 7(49), 81241-81254. https://doi.org/10.18632/oncotarget.13220

@article{869e4dd682b7476990a1f0c2163a410d,

title = "Lung tissue remodelling in MCT-induced pulmonary hypertension: a proposal for a novel scoring system and changes in extracellular matrix and fibrosis associated gene expression.",

keywords = "CARDIAC ALLOGRAFT-REJECTION, SERUM TENASCIN-C, CELLULAR FIBRONECTIN, ARTERIAL-HYPERTENSION, ED-A(+) FIBRONECTIN, TARGETED THERAPY, PLASMA-LEVELS, DISEASE, MATRIX-METALLOPROTEINASE-9, BIOMARKERS",

author = "Marcus Franz and Katja Gr{\"u}n and Stefan Betge and Ilonka Rohm and Bernadin Ndongson-Dongmo and Reinhard Bauer and Schulze, \{P Christian\} and Michael Lichtenauer and Iver Petersen and Dario Neri and Alexander Berndt and Christian Jung",

note = "Lichtenauer: Clinic of Internal Medicine II, Department of Cardiology, Paracelsus Medical University of Salzburg, Austria",

year = "2016",

doi = "10.18632/oncotarget.13220",

language = "English",

volume = "7",

pages = "81241--81254",

journal = "Oncotarget",

issn = "1949-2553",

number = "49",

}

Franz, M, Grün, K, Betge, S, Rohm, I, Ndongson-Dongmo, B, Bauer, R, Schulze, PC, Lichtenauer, M, Petersen, I, Neri, D, Berndt, A & Jung, C 2016, 'Lung tissue remodelling in MCT-induced pulmonary hypertension: a proposal for a novel scoring system and changes in extracellular matrix and fibrosis associated gene expression.', Oncotarget, Jg. 7, Nr. 49, S. 81241-81254. https://doi.org/10.18632/oncotarget.13220

TY - JOUR

T1 - Lung tissue remodelling in MCT-induced pulmonary hypertension: a proposal for a novel scoring system and changes in extracellular matrix and fibrosis associated gene expression.

AU - Franz, Marcus

AU - Grün, Katja

AU - Betge, Stefan

AU - Rohm, Ilonka

AU - Ndongson-Dongmo, Bernadin

AU - Bauer, Reinhard

AU - Schulze, P Christian

AU - Lichtenauer, Michael

AU - Petersen, Iver

AU - Neri, Dario

AU - Berndt, Alexander

AU - Jung, Christian

N1 - Lichtenauer: Clinic of Internal Medicine II, Department of Cardiology, Paracelsus Medical University of Salzburg, Austria

PY - 2016

Y1 - 2016

KW - CARDIAC ALLOGRAFT-REJECTION

KW - SERUM TENASCIN-C

KW - CELLULAR FIBRONECTIN

KW - ARTERIAL-HYPERTENSION

KW - ED-A(+) FIBRONECTIN

KW - TARGETED THERAPY

KW - PLASMA-LEVELS

KW - DISEASE

KW - MATRIX-METALLOPROTEINASE-9

KW - BIOMARKERS

U2 - 10.18632/oncotarget.13220

DO - 10.18632/oncotarget.13220

M3 - Original Article

C2 - 27835899

SN - 1949-2553

VL - 7

SP - 81241

EP - 81254

JO - Oncotarget

JF - Oncotarget

IS - 49

ER -